Literature DB >> 7756651

Analysis of the human CD10/neutral endopeptidase 24.11 promoter region: two separate regulatory elements.

F Ishimaru1, M A Shipp.   

Abstract

The cell surface zinc metalloproteinase CD10/neutral endopeptidase 24.11 (NEP) is expressed on normal and malignant lymphoid progenitors, granulocytes, and a variety of epithelial cells. To further define the tissue-specific and developmentally related expression of CD10/NEP, we have characterized two separate regulatory regions that control the transcription of 5' alternatively spliced CD10/NEP transcripts. These type 1 and 2 CD10/NEP regulatory regions are both characterized by the presence of multiple transcription initiation sites and the absence of classic TATA boxes and consensus initiator elements. The purine-rich type 1 regulatory region, which includes 5' UTR exon 1 sequence, is characterized by multiple putative PU.1 binding sites and consensus ets-binding motifs. In marked contrast, the GC-rich type 2 regulatory region contains multiple putative Sp1 binding sites, a potential consensus retinoblastoma control element (RCE), and an inverted CCAAT box. In the majority of tissues examined to date, type 2 CD10/NEP transcripts were more abundant; the abundance of type 1 transcripts was more variable, with the highest type 1 levels in fetal thymus and certain lymphoblastic leukemia cell lines.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7756651

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  13 in total

1.  The potent enhancer activity of the polycythemic strain of spleen focus-forming virus in hematopoietic cells is governed by a binding site for Sp1 in the upstream control region and by a unique enhancer core motif, creating an exclusive target for PEBP/CBF.

Authors:  C Baum; K Itoh; J Meyer; C Laker; Y Ito; W Ostertag
Journal:  J Virol       Date:  1997-09       Impact factor: 5.103

2.  Valproic acid-mediated inhibition of trimethyltin-induced deficits in memory and learning in the rat does not directly depend on its anti-oxidant properties.

Authors:  M A Edalatmanesh; M Hosseini; S Ghasemi; S Golestani; H R Sadeghnia; S M Mousavi; F Vafaee
Journal:  Ir J Med Sci       Date:  2015-02-01       Impact factor: 1.568

3.  Identification and functional characterization of pVHL-dependent cell surface proteins in renal cell carcinoma.

Authors:  Gunther Boysen; Damaris Bausch-Fluck; Claudio R Thoma; Anna M Nowicka; Daniel P Stiehl; Igor Cima; Van-Duc Luu; Adriana von Teichman; Thomas Hermanns; Tullio Sulser; Barbara Ingold-Heppner; Niklaus Fankhauser; Roland H Wenger; Wilhelm Krek; Peter Schraml; Bernd Wollscheid; Holger Moch
Journal:  Neoplasia       Date:  2012-06       Impact factor: 5.715

4.  Acute ethanol administration differentially alters enkephalinase and aminopeptidase N activity and mRNA levels in regions of the nigrostriatal pathway.

Authors:  Marcela Morales-Mulia; Patricia de Gortari; María-Isabel Amaya; Milagros Méndez
Journal:  J Mol Neurosci       Date:  2012-06-12       Impact factor: 3.444

5.  The transcriptionally active amyloid precursor protein (APP) intracellular domain is preferentially produced from the 695 isoform of APP in a {beta}-secretase-dependent pathway.

Authors:  Nikolai D Belyaev; Katherine A B Kellett; Caroline Beckett; Natalia Z Makova; Timothy J Revett; Natalia N Nalivaeva; Nigel M Hooper; Anthony J Turner
Journal:  J Biol Chem       Date:  2010-10-20       Impact factor: 5.157

6.  NF-kappaB down-regulates expression of the B-lymphoma marker CD10 through a miR-155/PU.1 pathway.

Authors:  Ryan C Thompson; Melanie Herscovitch; Ian Zhao; Tyler J Ford; Thomas D Gilmore
Journal:  J Biol Chem       Date:  2010-10-14       Impact factor: 5.157

7.  Neprilysin gene expression requires binding of the amyloid precursor protein intracellular domain to its promoter: implications for Alzheimer disease.

Authors:  Nikolai D Belyaev; Natalia N Nalivaeva; Natalia Z Makova; Anthony J Turner
Journal:  EMBO Rep       Date:  2008-12-05       Impact factor: 8.807

8.  Association of neprilysin polymorphism with cerebral amyloid angiopathy.

Authors:  M Yamada; N Sodeyama; Y Itoh; A Takahashi; E Otomo; M Matsushita; H Mizusawa
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-06       Impact factor: 10.154

9.  A neprilysin polymorphism and amyloid-beta plaques after traumatic brain injury.

Authors:  Victoria E Johnson; William Stewart; David I Graham; Janice E Stewart; Amy H Praestgaard; Douglas H Smith
Journal:  J Neurotrauma       Date:  2009-08       Impact factor: 5.269

10.  Hypoxia-induced down-regulation of neprilysin by histone modification in mouse primary cortical and hippocampal neurons.

Authors:  Zheng Wang; Dehua Yang; Xiaojie Zhang; Ting Li; Jia Li; Yu Tang; Weidong Le
Journal:  PLoS One       Date:  2011-04-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.